US Patent Issued to MESOESTETIC PHARMA GROUP, S.L on Feb. 24 for "Tyrosinase-inhibiting molecules and dermopharmaceutical composition that includes them" (Spanish Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,302, issued on Feb. 24, was assigned to MESOESTETIC PHARMA GROUP, S.L (Barcelona, Spain).

"Tyrosinase-inhibiting molecules and dermopharmaceutical composition that includes them" was invented by Alfredo Martinez Gutierrez (Barcelona, Spain), Alexandra Bertran Junque (Barcelona, Spain), Maria del Carmen Gonzalez Rodriguez (Barcelona, Spain), Sergio Pascual Del Prado (Barcelona, Spain) and Luis Shotze Luis Garcia (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides tyrosinase-inhibiting molecules of general formula (I) and a dermopharmaceutical or cosmetic composition that includes at least one of said tyrosi...